Sewoon Medical Co (100700) Fair Value & Analysis
Healthcare · KR · Market cap 95.5B KRW
Fair value as of: Jul 22, 2026
From 22 valuation models · updated 19 days ago
Share price −0.8% over the past month.
A strong business, screening 154% undervalued on our models.
What matters now
- The rarer combination: high quality (76/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (4,540 KRW). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range 2,075 KRW – 5,725 KRW · fair‑value band 4,540 KRW – 7,567 KRW · the 2,380 KRW price screens below the 6,054 KRW fair value. Dashed = 300-day average. As of Jul 22, 2026.
Analysis
Sewoon Medical Co (100700) currently trades at 2,380 KRW, while our model-based Fair Value estimate is 6,054 KRW, implying the stock looks roughly 154.4% undervalued today. The Quality Score stands at 76/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Sewoon Medical Co generated revenue of 60.3B KRW at a net margin of 17.9%. Revenue declined 5.2% year over year. Fundamentals as of Jul 22, 2026
Our scenario range runs from 4,540 KRW (bear case) to 7,567 KRW (bull case); at 2,380 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -11% fair-value upside, at 154%, 100700 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: DCF Models (7,137 KRW) versus Asset-Based (2,340 KRW). Highest evidence: Growth DCF (80).
Notify me when 100700 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 75 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products.
Full company description
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical Co., Ltd. was founded in 1982 and is headquartered in Cheonan, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sewoon Medical Co reported revenue of 63.7B KRW in FY2025 versus 62.6B KRW in FY2021, a compound +0.4%/yr. Reported net income was 11.9B KRW in FY2025, compounding −0.8%/yr from FY2021.
Watch 100700: get an alert when its fair value changes →
Peer Group
Health Care · 2227 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)
Valuation Multiples vs Health Care median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 50,900 KRW | 49,984 KRW | -2% |
| i-SENS, Inc 099190 | 15,270 KRW | 8,168 KRW | -47% |
| Value Added Technology Co 043150 | 16,800 KRW | 60,242 KRW | +259% |
| Mediana Co 041920 | 8,940 KRW | 6,289 KRW | -30% |
| Meta Biomed Co 059210 | 3,830 KRW | 9,875 KRW | +158% |
| MEDIC MEDIC | 0.2100 PHP | 0.1400 PHP | -33% |
| MEKICS CO., Ltd 058110 | 1,780 KRW | 1,584 KRW | -11% |
| CU Medical Systems, Inc 115480 | 1,753 KRW | 1,134 KRW | -35% |
| PeopleBio, Inc 304840 | 857.00 KRW | 905.70 KRW | +6% |
| Novartis AG NVSN | 2,742 MXN | 2,379 MXN | -13% |
Compare Sewoon Medical Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sewoon Medical Co (100700) overvalued or undervalued?
What is the fair value of 100700?
What is the quality score of 100700?
What is the revenue of Sewoon Medical Co (100700)?
What is the net profit margin of 100700?
Does Sewoon Medical Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Sewoon Medical Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.